| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 02/24/2000 | CA2338386A1 Proteases and associated proteins |
| 02/24/2000 | CA2338184A1 Bacterial superantigen vaccines |
| 02/24/2000 | CA2336147A1 N-linked sulfonamides of n-heterocyclic carboxylic acids or isosteres for vision and memory disorders |
| 02/24/2000 | CA2335813A1 N-oxides of heterocyclic ester, amide, thioester, or ketone for vision and memory disorders |
| 02/24/2000 | CA2280582A1 Compositions and methods for protecting animals from lentivirus-associated disease such as feline immunodeficiency virus |
| 02/23/2000 | EP0980432A1 Chimeric opg polypeptides |
| 02/23/2000 | EP0980390A2 Human-cd28 specific monoclonal antibodies for antigen non-specific activation of t-lymphocytes |
| 02/23/2000 | EP0980389A1 Antigen |
| 02/23/2000 | EP0980385A1 Peptides and compounds that bind to the il-5 receptor |
| 02/23/2000 | EP0980383A1 Pharmaceutically acceptable salts of 3-hydroxy-estr-5(10)-en-17-one 3-sulphate active as estrogens |
| 02/23/2000 | EP0980369A1 Sulfonamides for treatment of endothelin-mediated disorders |
| 02/23/2000 | EP0980362A1 Substituted heterocycles and their use in medicaments |
| 02/23/2000 | EP0980359A1 Benzimidazole derivative |
| 02/23/2000 | EP0980354A2 Vitamin d 3? analogs with bis c-20 side chains |
| 02/23/2000 | EP0980259A1 Use of a cd40:cd154 binding interruptor to prevent counter adaptive immune responses, particularly graft rejection |
| 02/23/2000 | EP0980258A1 Suppression of tumor necrosis factor alpha and vascular endothelial growth factor in therapy |
| 02/23/2000 | EP0980249A1 Use of cd26 inhibitor for the manufacture of a medicament for the treatment of hiv |
| 02/23/2000 | EP0980242A2 Use of fumaric acid derivatives |
| 02/23/2000 | EP0898579B1 Pregnane derivatives with no alpha-17 substitutent, their medicinal use, manufacturing method and its intermediaries and related compounds |
| 02/23/2000 | EP0832063B1 Vitamin d derivatives with c-25 substituents, process for their preparation, intermediate products and their use in preparing medicaments |
| 02/23/2000 | CN1245536A Novel calpaines, production and use thereof |
| 02/23/2000 | CN1245490A Sulfonyl urea derivatives and their use in control of interleukin-1 activity |
| 02/23/2000 | CN1049659C Corticotropin releasing factor antagonists |
| 02/23/2000 | CN1049651C Metalloproteinase inhibitors |
| 02/22/2000 | US6028169 Chemokine β-6 antagonists |
| 02/22/2000 | US6028114 Use of aminothiolester derivatives in pharmaceutics |
| 02/22/2000 | US6028098 Use of cis-or transurocamic acid for the treatment of photodermatoses and immunogenic skin diseases |
| 02/22/2000 | US6028097 Method of immunosuppression |
| 02/22/2000 | US6028086 Selective inhibitors of phosphodiesterase (pde) type iv or production of tumor necrosis factor (tnf) and as such are useful treatment of asthma, arthritis, bronchitis, chronic obstructive airways disease, psoriasis, allergic rhinitis |
| 02/22/2000 | US6028074 Pyrazolo[3,4-d]pyrimidineone compounds |
| 02/22/2000 | US6027735 Improving nutrient utilization in an animal or human by immunizing orally or parenterally with an antigen to initiating digestion, stimulating the secretion of digestive acids and enzymes, increasing the blood flow and stimulating |
| 02/22/2000 | US6027732 Iscom or iscom-matrix comprising hydrophobic receptor molecules for antigenic substances |
| 02/22/2000 | US6027725 Multivalent antigen-binding proteins |
| 02/22/2000 | US6027711 Structurally determined metallo-constructs and applications |
| 02/22/2000 | CA2170607C Difluoro statone antiviral analogs |
| 02/22/2000 | CA2003455C Immunotherapy involving cd28 stimulation |
| 02/17/2000 | WO2000008463A2 Immunoadsorber for removing endotoxins |
| 02/17/2000 | WO2000008202A2 3-methylidenyl-2-indolinone modulators of protein kinase |
| 02/17/2000 | WO2000008191A2 Herpes virus vectors for dendritic cells |
| 02/17/2000 | WO2000008177A2 Death associated kinase containing ankyrin repeats (dakar) |
| 02/17/2000 | WO2000008158A2 Molecules designated ldcam |
| 02/17/2000 | WO2000008144A1 Dna encoding a human inhibitor-of-apoptosis protein; hiap3 |
| 02/17/2000 | WO2000008048A2 Inhibitor of histone deacetylase |
| 02/17/2000 | WO2000008007A2 Cyclopentabenzofuran derivatives and their use |
| 02/17/2000 | WO2000007991A1 Amide derivatives useful as inhibitors of the production of cytokines |
| 02/17/2000 | WO2000007980A1 Amide derivatives which are useful as cytokine inhibitors |
| 02/17/2000 | WO2000007621A2 Vaccine comprising an iscom consisting of sterol and saponin which is free of additional detergent |
| 02/17/2000 | WO2000007610A1 Interacting proteins for autoantigens of autoimmune diseases |
| 02/17/2000 | WO2000007609A1 Peptide antagonists of zonulin and methods for use of the same |
| 02/17/2000 | WO2000007594A1 Use of il-2 inhibitors in the treatment of rheumatoid arthritis |
| 02/17/2000 | WO2000007591A1 INDOLE sPLA2 INHIBITORS |
| 02/17/2000 | WO2000007590A1 INDOLE sPLA2 INHIBITORS |
| 02/17/2000 | WO2000007567A1 Medicinal aerosol formulations |
| 02/17/2000 | WO2000001815A3 Neurotrophic factors |
| 02/17/2000 | WO1999065942A8 Cyclic somatostatin analogs |
| 02/17/2000 | WO1999056763A9 Use of neglected target tissue antigens in modulation of immune responses |
| 02/17/2000 | WO1999055859A3 Cd40-interacting and traf-interacting proteins |
| 02/17/2000 | WO1999054310A3 New substituted amides, their production and their use |
| 02/17/2000 | WO1999053036A9 Ste20-related protein kinases |
| 02/17/2000 | WO1999045955A9 DIAGNOSIS, PREVENTION AND TREATMENT OF ULCERATIVE COLITIS, AND CLINICAL SUBTYPES THEREOF, USING MICROBIAL UC pANCA ANTIGENS |
| 02/17/2000 | CA2383623A1 3-methylidenyl-2-indolinone modulators of protein kinase |
| 02/17/2000 | CA2339486A1 Vaccine comprising an iscom consisting of sterol and saponin which is free of additional detergent |
| 02/17/2000 | CA2339086A1 Dna replication- and repair-associated proteins |
| 02/17/2000 | CA2338855A1 Indole spla2 inhibitors |
| 02/17/2000 | CA2338727A1 Indole spla2 inhibitors |
| 02/17/2000 | CA2338385A1 Human receptor-associated proteins |
| 02/17/2000 | CA2338121A1 Amide derivatives useful as inhibitors of the production of cytokines |
| 02/17/2000 | CA2305680A1 Death associated kinase containing ankyrin repeats (dakar) |
| 02/16/2000 | EP0979867A2 Immunodominant human T-cell epitopes of hepatitis C virus |
| 02/16/2000 | EP0979289A1 Human lysophospholipase |
| 02/16/2000 | EP0979284A2 Methods and reagents for vaccination which generate a cd8 t cell immune response |
| 02/16/2000 | EP0979275A1 Novel human mago nashi protein |
| 02/16/2000 | EP0979244A1 Novel cyclosporin derivatives, preparation and pharmaceutical compositions containing same |
| 02/16/2000 | EP0979230A1 6,7-disubstituted-4-aminopyrido[2,3-d]pyrimidine compounds |
| 02/16/2000 | EP0979228A1 Novel cannabinoid receptor agonists |
| 02/16/2000 | EP0979099A1 Use of lactoferin in the treatment of allergen induced disorders |
| 02/16/2000 | EP0979085A1 Treatment of eosinophil-associated pathologies, such as bronchial asthma, with synergistic combinations of glucocorticoids and a local anesthetics |
| 02/16/2000 | EP0979082A1 Antiviral combinations containing the carbocyclic nucleoside 1592u89 |
| 02/16/2000 | EP0979080A1 A method of modulating an immune response in an infected mammal by transmucosal administration of modulating agent |
| 02/16/2000 | EP0979079A1 Use of tetrahydropyridine derivatives to prepare medicines for treating diseases causing demyelination |
| 02/16/2000 | EP0979078A1 Substituted bis-acridines and related compounds as ccr5 receptor ligands, anti-inflammatory agents and anti-viral agents |
| 02/16/2000 | CN1244867A Substitued nitrogen containing heterocycles as inhibitors of P38 protein kinase |
| 02/16/2000 | CN1244859A Benzenesulfonamide derivatives and drugs containing the same |
| 02/16/2000 | CN1244804A Peptide immunotherapeutic agent |
| 02/16/2000 | CN1244803A Soluble CTLA4 mutant molecules and uses thereof |
| 02/16/2000 | CN1244799A L-beta-dioxolane uridine analogs and method for treating and preventing virus infections |
| 02/16/2000 | CN1244414A Immune rheumatism capsule |
| 02/15/2000 | US6025494 Tetracyclic derivatives, process of preparation and use |
| 02/15/2000 | US6025468 Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens including immunogenic LHRH peptides |
| 02/15/2000 | US6025391 Enteric-coated pharmaceutical compositions of mycophenolate |
| 02/15/2000 | US6025376 Chiral methylphenyloxazolidinones |
| 02/15/2000 | US6025361 Effective pde iv inhibitors, asthma |
| 02/15/2000 | US6025354 Exhibit phosphodiesterase iv inhibition and can be used to treat asthmatic disorders. |
| 02/15/2000 | US6025349 Phenyl.-substituted alkenylcarboguanidides carrying perfluoroalkyl groups, a process for their preparation, their use as a medicament or diagnostic agent, and also a medicament containing them |
| 02/15/2000 | US6025343 Lipid esters of nucleoside monophosphates and their use as immunosuppressive drugs |
| 02/15/2000 | US6025334 Extracts of shark cartilage having anti-collagenolytic, anti-inflammatory, anti-angiogenic and anti-tumoral activities; process of making, methods of using and compositions thereof |
| 02/15/2000 | US6025176 For diagnosis and monitoring of insulin dependent diabetes mellitis; antidiabetic agents |
| 02/15/2000 | US6025165 Producing single-chain molecules of the binding portions of variable regions of light and heavy chains joined by peptide linker, dissociating then reassociating the molecules, separating out and recovering multivalent proteins |
| 02/15/2000 | US6025162 Nucleic acid encoding an amino acid sequence of protein; for diagnosis and treatment of allergies |
| 02/15/2000 | US6025147 Inhibitors of interleukin-1 β converting enzyme |